TNF Inhibitor Use, Follicular Lymphoma Risk Linked Among Patients With RA

September 18th 2021, 12:00pm


Patients with rheumatoid arthritis (RA) who used tumor necrosis factor (TNF) inhibitors had significantly higher rates of nonmelanoma skin cancer and non-Hodgkin lymphoma.

Early Lung Screening May Be Beneficial in RA, Study Finds

September 15th 2021, 2:55pm


A new study lends insights into the prevalence of lung abnormalities in patients with newly diagnosed cases of rheumatoid arthritis (RA).

Belimumab Fails to Slow Relapses in Children With FRNS

September 11th 2021, 7:30pm


In pediatric patients with frequently relapsing nephrotic syndrome (FRNS), the therapy was well tolerated, but did not lead to significant changes in disease course.

New Analysis Identifies Biomarker for Rheumatoid Arthritis Risk

September 8th 2021, 3:10pm


The new study, based on an analysis of existing literature and a replication cohort, helps clarify the role of a variant in microRNA-146a.

Machine Learning Algorithm Finds Links Between Adverse Childhood Experiences, Rheumatic Diseases

September 1st 2021, 6:35pm


People who suffered trauma as a child appear to be at a higher risk of fibromyalgia, although it is unclear exactly why.

Access to Therapy and Future Treatment Directions in Lupus Nephritis

August 26th 2021, 1:00pm


German Hernandez, MD, FASN, FACP, and Ellen Ginzler, MD, MPH, discuss barriers to treatment access in lupus nephritis, and address future directions and unmet needs of the disease.

Patients With Autoimmune Rheumatic Diseases Often Wait Months Before Diagnosis

August 24th 2021, 6:51pm


Patients with axial spondyloarthritis waited the longest, according to new research.

FDA Approved Agents for Lupus Nephritis: Belimumab and Voclosporin

August 24th 2021, 1:00pm


German Hernandez, MD, FASN, FACP, and Ellen Ginzler, MD, MPH, provide insight into the FDA approved therapies for lupus nephritis, belimumab and voclosporin, including an overview of clinical evidence, mechanism of action, and patient selection.

Treatment Landscape and Choice of Therapy in Lupus Nephritis

August 19th 2021, 1:00pm


Rheumatology and nephrology experts provide an overview of the pharmacologic treatment options in lupus nephritis and discuss recent FDA approved therapies belimumab and voclosporin.

Two-Year Results Affirm Efficacy of Secukinumab in Psoriatic Arthritis

August 17th 2021, 8:00pm


Results from the FUTURE 5 study show that more than 80% of patients had no radiographic progression of psoriatic arthritis, regardless of dose cohort or whether a loading dose was used.